Literature DB >> 12442563

The prognosis after multidisciplinary treatment for patients with postinfectious chronic fatigue syndrome and noninfectious chronic fatigue syndrome.

Akinori Masuda1, Takashi Nakayama, Takao Yamanaka, Yasuyuki Koga, Chuwa Tei.   

Abstract

The prognosis after multidisciplinary treatment for patients with postinfectious chronic fatigue syndrome (CFS, n = 9) and noninfectious CFS (n = 9) was clarified. After treatment, natural killer (NK) cell activity increased in the postinfectious CFS group but did not recover to within normal range in the noninfectious CFS group. In the postinfectious CFS group, physical and mental symptoms improved, and 8 patients returned to work. In the noninfectious CFS group, symptoms did not improve, and only 3 patients returned to work. The prognosis of postinfectious CFS group was better than that of noninfectious CFS group. Classification of CFS patients into postinfectious and noninfectious groups is useful for choosing the appropriate treatment in order to obtain better prognosis.

Entities:  

Mesh:

Year:  2002        PMID: 12442563     DOI: 10.1023/a:1020475108745

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  21 in total

1.  Precipitating factors for the chronic fatigue syndrome.

Authors:  I E Salit
Journal:  J Psychiatr Res       Date:  1997 Jan-Feb       Impact factor: 4.791

2.  Epidemiologic advances in chronic fatigue syndrome.

Authors:  P H Levine
Journal:  J Psychiatr Res       Date:  1997 Jan-Feb       Impact factor: 4.791

3.  Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome.

Authors:  K Y Fulcher; P D White
Journal:  BMJ       Date:  1997-06-07

Review 4.  Treatment of patients with chronic fatigue syndrome.

Authors:  N M Gantz; G P Holmes
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

5.  Prognosis in chronic fatigue syndrome: a prospective study on the natural course.

Authors:  J H Vercoulen; C M Swanink; J F Fennis; J M Galama; J W van der Meer; G Bleijenberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

Review 6.  The treatment of chronic fatigue syndrome: science and speculation.

Authors:  A Wilson; I Hickie; A Lloyd; D Wakefield
Journal:  Am J Med       Date:  1994-06       Impact factor: 4.965

7.  Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial.

Authors:  A Deale; T Chalder; I Marks; S Wessely
Journal:  Am J Psychiatry       Date:  1997-03       Impact factor: 18.112

8.  The psychiatric status of patients with the chronic fatigue syndrome.

Authors:  I Hickie; A Lloyd; D Wakefield; G Parker
Journal:  Br J Psychiatry       Date:  1990-04       Impact factor: 9.319

9.  Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial.

Authors:  S E Straus; J K Dale; M Tobi; T Lawley; O Preble; R M Blaese; C Hallahan; W Henle
Journal:  N Engl J Med       Date:  1988-12-29       Impact factor: 91.245

Review 10.  Postviral fatigue syndrome and psychiatry.

Authors:  A S David
Journal:  Br Med Bull       Date:  1991-10       Impact factor: 4.291

View more
  5 in total

Review 1.  Chronic fatigue syndrome: the need for subtypes.

Authors:  Leonard A Jason; Karina Corradi; Susan Torres-Harding; Renee R Taylor; Caroline King
Journal:  Neuropsychol Rev       Date:  2005-03       Impact factor: 7.444

2.  Chronic fatigue and indicators of long-term employment disability in psychosomatic inpatients.

Authors:  Karin Tritt; Marius Nickel; Ferdinand Mitterlehner; Cerstin Nickel; Petra Forthuber; Peter Leiberich; Wolfhardt Rother; Thomas Loew
Journal:  Wien Klin Wochenschr       Date:  2004-03-31       Impact factor: 1.704

3.  A systematic review of chronic fatigue syndrome: don't assume it's depression.

Authors:  James P Griffith; Fahd A Zarrouf
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

4.  Investigating unexplained fatigue in general practice with a particular focus on CFS/ME.

Authors:  Amolak S Bansal
Journal:  BMC Fam Pract       Date:  2016-07-19       Impact factor: 2.497

5.  Immunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome.

Authors:  Kurt Hanevik; Einar K Kristoffersen; Steinar Sørnes; Kristine Mørch; Halvor Næss; Ann C Rivenes; Jørn E Bødtker; Trygve Hausken; Nina Langeland
Journal:  BMC Infect Dis       Date:  2012-10-14       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.